8th European Conference on Rare Diseases and Orphan Products

The European Conference on Rare Diseases and Orphan Products is the unique platform/forum across all rare diseases, across all European countries, bringing together all stakeholders - patients representatives, academics, researchers, health care professionals, industry, payers, regulators and policy makers.

ECRD provides the state-of-the-art of the rare disease environment, monitoring and benchmarking initiatives.

ECRD covers research, development of new treatments, health care, social care, information, public health and support at European, national, regional and international levels.

Prices:
Early-bird: Pharmaceutical industry, ERTC members, consultants, investors: EUR 1200
Early-bird: Academics / Health care professionals: EUR
Early-bird: EURORDIS members: EUR 110
Early-bird: Patients Organisations (non-EURORDIS members): EUR
Early-bird: Medical students /post-graduate trainees: EUR 110
Early-bird: Government workers/policy makers/ payers/ regulators: EUR 310

Speakers: Alastair Kent (Director, Genetic Alliance UK), Bruno Sepodes (Chair COMP, Professor at the University of Lisbon, Portugal), Wills Hughes-Wilson (Task Force RDs and ODs of EFPIA - EuropaBio, Vice President External Affairs, Chief Patient Access Officer, Swedish Orphan Biovitrum (sobi), Member of DIA Advisory Council Europe)